Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study
Source
PLoS ONE - ISSN 1932-6203-19:7 (2024) p. 1-15
Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma : protocol of a monocentric phase I/II clinical trial in Belgium
Source
BMJ open - ISSN 2044-6055-14:3 (2024) p. 1-10
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
Source
Blood - ISSN 0006-4971-130:15 (2017) p. 1713-1721
The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells
Source
Oncotarget - ISSN 1949-2553-7:45 (2016) p. 73960-73970
Generation and cryopreservation of clinical grade Wilms' tumor 1 mRNA-loaded dendritic cell vaccines for cancer immunotherapy
Source
Methods in molecular biology - ISSN 1064-3745-1393 (2016) p. 27-35